LI, David Yunzhi,WANG, Jiabing,YANG, Zhenfan,ZENG, Qingbei,ZHANG, Xiaolin
申请号：
MEP2017259
公开号：
ME03041B
申请日:
2014.03.05
申请国别(地区):
ME
年份:
2018
代理人:
摘要：
The invention relates to compounds of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I) which possess inhibitory activity against activating mutant forms of EGFR, and are accordingly useful for their anti-cancer activity and in methods of treatment of the human or animal body. The invention also relates pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti- cancer effect in a warm-blooded animal such as man.
